A post-hoc REDEFINE 1 analysis in 2,309 women showed 25.0% average weight loss on CagriSema at 68 weeks, assuming full adherence. A judge also denied Novo's bid to block Lilly ads.
Recap by typeshit. Full story at ad-hoc-news.de.
Tara Wider has spent about five years posting on holistic beauty and women's wellness, building a following of women her age on social media.
Brown says diet and exercise still matter, but argues that shaming people for treating obesity with medication has never made anyone healthier.
A short share on growing GLP-1 use in the US, with no figures or sources attached. Thin on detail beyond the headline itself.
A new survey covered by Chain Store Age tracks how GLP-1 users are shifting their food spending from restaurants toward grocery stores.
Barzilai highlights trial results on retatrutide in adults with sleep apnea and obesity or overweight, a new use being tested for Lilly's drug.
A lighthearted Friday post from Saroni about friends refusing to believe her answer on how she lost weight. No details on the drug itself.
Loading…